WAVE Life Sciences (WVE) Insider Trading & Ownership $8.09 -0.04 (-0.49%) Closing price 04:00 PM EasternExtended Trading$8.09 0.00 (-0.06%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock WAVE Life Sciences (NASDAQ:WVE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.98%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$22.34MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$8.68M Get WVE Insider Trade Alerts Want to know when executives and insiders are buying or selling WAVE Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address WVE Insider Buying and Selling by Quarter WAVE Life Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/5/2025Ken TakanashiDirectorSell4,872$8.75$42,630.00 6/13/2025Gregory L VerdineDirectorSell30,000$6.95$208,500.00 3/20/2025Christian O HenryDirectorSell10,500$9.77$102,585.00 3/7/2025Paul BolnoCEOSell169,025$9.57$1,617,569.25 11/25/2024Paul BolnoCEOSell50,000$15.00$750,000.00 11/15/2024Paul BolnoCEOSell51,234$14.32$733,670.88 11/8/2024Chris FrancisinsiderSell36,000$16.00$576,000.00 10/16/2024Chris FrancisinsiderSell208,836$13.67$2,854,788.12 10/16/2024Paul BolnoCEOSell90,474$15.00$1,357,110.00 9/27/2024Plc GskMajor ShareholderBuy2,791,930$8.00$22,335,440.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/25/2024Kyle MoranCFOSell17,146$9.00$154,314.00 8/21/2024Paul BolnoCEOSell48,366$5.78$279,555.48 (Data available from 1/1/2013 forward) WVE Insider Trading Activity - Frequently Asked Questions Who is on WAVE Life Sciences' Insider Roster? The list of insiders at WAVE Life Sciences includes Chandra Vargeese, Chris Francis, Christian O Henry, Gregory L Verdine, Ken Takanashi, Kyle Moran, Paul Bolno, Plc Gsk, and Ra Capital Management, L.P.. Learn more on insiders at WVE. What percentage of WAVE Life Sciences stock is owned by insiders? 23.98% of WAVE Life Sciences stock is owned by insiders. Learn more on WVE's insider holdings. Which WAVE Life Sciences insiders have been buying company stock? The following insiders have purchased WVE shares in the last 24 months: Plc Gsk ($22,335,440.00), and Ra Capital Management, L.P. ($5,000,000.00). How much insider buying is happening at WAVE Life Sciences? Insiders have purchased a total of 3,791,930 WVE shares in the last 24 months for a total of $27,335,440.00 bought. Which WAVE Life Sciences insiders have been selling company stock? The following insiders have sold WVE shares in the last 24 months: Chris Francis ($3,430,788.12), Christian O Henry ($102,585.00), Gregory L Verdine ($208,500.00), Ken Takanashi ($42,630.00), Kyle Moran ($426,795.60), and Paul Bolno ($4,737,905.61). How much insider selling is happening at WAVE Life Sciences? Insiders have sold a total of 769,145 WAVE Life Sciences shares in the last 24 months for a total of $8,949,204.33 sold. WAVE Life Sciences Key ExecutivesDr. Paul B. Bolno M.B.A. (Age 50)M.D., President, CEO & Director Compensation: $1.13MMr. Kyle B. Moran CFA (Age 53)CFO & Principal Accounting Officer Compensation: $726.34kDr. Chandra Vargeese Ph.D. (Age 63)Chief Technology Officer Compensation: $731.8kDr. Erik IngelssonChief Scientific OfficerKate RauschHead of Investor RelationsMs. Linda Rockett J.D.Senior VP & General CounselDr. Christopher Francis Ph.D. (Age 46)Senior VP of Corporate Development & Head of Emerging Areas Compensation: $493.13kMs. Daryn LewisSenior VP & Head of Human ResourcesDr. Sridhar Vaddeboina Ph.D.Senior Vice President of Chemistry, Manufacturing & ControlsMs. Anne-Marie Li-Kwai-CheungChief Development Officer More Insider Trading Tools from MarketBeat Related Companies AXSM Insider Trades LNTH Insider Trades CRSP Insider Trades ADMA Insider Trades MRUS Insider Trades KRYS Insider Trades CYTK Insider Trades RNA Insider Trades PCVX Insider Trades PTCT Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:WVE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WAVE Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share WAVE Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
